NL175410B - METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-HISTAMINIC, SOURCE CHODILATORY AND ANTI-ALLERGIC EFFECT, PRODUCED PHARMACEUTICAL PREPARATIONS OBTAINED THEREFROM, AND METHOD FOR PREPARING FOR A PREPARED PROPERTY. - Google Patents

METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-HISTAMINIC, SOURCE CHODILATORY AND ANTI-ALLERGIC EFFECT, PRODUCED PHARMACEUTICAL PREPARATIONS OBTAINED THEREFROM, AND METHOD FOR PREPARING FOR A PREPARED PROPERTY.

Info

Publication number
NL175410B
NL175410B NLAANVRAGE7300873,A NL7300873A NL175410B NL 175410 B NL175410 B NL 175410B NL 7300873 A NL7300873 A NL 7300873A NL 175410 B NL175410 B NL 175410B
Authority
NL
Netherlands
Prior art keywords
chodilatory
histaminic
preparing
manufacturing
source
Prior art date
Application number
NLAANVRAGE7300873,A
Other languages
Dutch (nl)
Other versions
NL7300873A (en
NL175410C (en
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22829539&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL175410(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NL7300873A publication Critical patent/NL7300873A/xx
Publication of NL175410B publication Critical patent/NL175410B/en
Application granted granted Critical
Publication of NL175410C publication Critical patent/NL175410C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
NLAANVRAGE7300873,A 1972-01-28 1973-01-22 METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-HISTAMINIC, SOURCE CHODILATORY AND ANTI-ALLERGIC EFFECT, PRODUCED PHARMACEUTICAL PREPARATIONS OBTAINED THEREFROM, AND METHOD FOR PREPARING FOR A PREPARED PROPERTY. NL175410C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22182172A 1972-01-28 1972-01-28

Publications (3)

Publication Number Publication Date
NL7300873A NL7300873A (en) 1973-07-31
NL175410B true NL175410B (en) 1984-06-01
NL175410C NL175410C (en) 1984-11-01

Family

ID=22829539

Family Applications (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7300873,A NL175410C (en) 1972-01-28 1973-01-22 METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-HISTAMINIC, SOURCE CHODILATORY AND ANTI-ALLERGIC EFFECT, PRODUCED PHARMACEUTICAL PREPARATIONS OBTAINED THEREFROM, AND METHOD FOR PREPARING FOR A PREPARED PROPERTY.

Country Status (26)

Country Link
JP (1) JPS5115035B2 (en)
AR (1) AR195314A1 (en)
AT (2) AT323742B (en)
AU (1) AU467361B2 (en)
BE (1) BE794597A (en)
CA (1) CA978946A (en)
CH (2) CH587820A5 (en)
CS (1) CS177834B2 (en)
DD (1) DD103239A5 (en)
DE (1) DE2303306C3 (en)
DK (1) DK136713B (en)
ES (1) ES410731A1 (en)
FR (1) FR2181690B1 (en)
GB (1) GB1413138A (en)
HU (1) HU166477B (en)
IE (1) IE36983B1 (en)
IL (1) IL41060A (en)
LU (1) LU66916A1 (en)
NL (1) NL175410C (en)
NO (1) NO140057C (en)
PH (1) PH10264A (en)
PL (1) PL89095B1 (en)
SE (1) SE382058B (en)
SU (1) SU464997A3 (en)
YU (1) YU36013B (en)
ZA (1) ZA728544B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941795A (en) 1974-02-08 1976-03-02 Richardson-Merrell Inc. α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES
US4254129A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
US4254130A (en) * 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
IT1200123B (en) * 1985-09-27 1989-01-05 Ind Chimica Srl PROCESS FOR ALPHA PREPARATION
US4742175A (en) * 1986-05-07 1988-05-03 Merrell Dow Pharmaceuticals Inc. Preparation of polymorphically pure terfenadine
JPS63101760U (en) * 1986-12-19 1988-07-02
IT1205685B (en) * 1987-05-26 1989-03-31 Erregierre Spa PROCESS FOR THE PREPARATION OF ALPHA- (ALCHYLPHENYL) -4- (HYDROXY DIPHENYLMETHYL) -1-PIPERIDINE BUTANOL
IL93499A0 (en) * 1989-02-28 1990-11-29 Merrell Dow Pharma Preparation of the low melting polymorphic form of terfenadine
CA2015390A1 (en) * 1989-05-01 1990-11-01 Frederick J. Mccarty Process for the preparation of the high melting polymorphic of terfenadine
DE3917241A1 (en) * 1989-05-26 1990-11-29 Schaper & Bruemmer Gmbh 4- (HYDROXYDIPHENYLMETHYL) -1-PIPERIDYL-PHENYLALKANE DERIVATIVES
EP0596120A4 (en) * 1991-08-09 1994-07-06 Yoshitomi Pharmaceutical Thiophene compound.
CA2216877A1 (en) * 1995-05-08 1996-11-14 Hoechst Marion Roussel, Inc. Alpha-(substituted alkylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
DE59810863D1 (en) * 1997-03-11 2004-04-08 Aventis Pharma Inc Process for the preparation of 4- (4- (4- (hydroxydiphenyl) -1-piperidinyl) -1-hydroxybutyl) alpha, alpha-dimenthylphenylacetic acid and phosphorylated derivatives
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US8153385B2 (en) 2004-10-18 2012-04-10 Reverse Proteomics Research Institute Co., Ltd. Target protein and target gene in drug designing and screening method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3081303A (en) * 1961-10-13 1963-03-12 Searle & Co 1-aminoalkyl-alpha, alpha-diphenylpiperidine-methanols
GB1242169A (en) * 1969-04-09 1971-08-11 Ucb Sa Piperidine derivatives

Also Published As

Publication number Publication date
IL41060A0 (en) 1973-02-28
PL89095B1 (en) 1976-10-30
SU464997A3 (en) 1975-03-25
YU36013B (en) 1981-11-13
AU467361B2 (en) 1975-11-27
JPS4885578A (en) 1973-11-13
AR195314A1 (en) 1973-09-28
CH587820A5 (en) 1977-05-13
NO140057C (en) 1979-07-04
FR2181690B1 (en) 1976-05-14
AT321917B (en) 1975-04-25
DE2303306B2 (en) 1978-09-28
CH593259A5 (en) 1977-11-30
IL41060A (en) 1975-06-25
AT323742B (en) 1975-07-25
BE794597A (en) 1973-05-16
YU3473A (en) 1981-02-28
NL7300873A (en) 1973-07-31
GB1413138A (en) 1975-11-05
FR2181690A1 (en) 1973-12-07
SE382058B (en) 1976-01-12
PH10264A (en) 1976-10-20
CS177834B2 (en) 1977-08-31
DD103239A5 (en) 1974-01-12
IE36983L (en) 1973-07-28
ZA728544B (en) 1974-02-27
DK136713B (en) 1977-11-14
ES410731A1 (en) 1976-04-01
DK136713C (en) 1978-05-01
AU4989372A (en) 1974-06-13
LU66916A1 (en) 1973-07-27
IE36983B1 (en) 1977-04-13
HU166477B (en) 1975-03-28
JPS5115035B2 (en) 1976-05-13
DE2303306A1 (en) 1973-08-02
DE2303306C3 (en) 1979-05-31
NO140057B (en) 1979-03-19
CA978946A (en) 1975-12-02
NL175410C (en) 1984-11-01

Similar Documents

Publication Publication Date Title
NL159102B (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH BLOOD PRESSURE-LOWERING ACTION AND WITH THEIR APPLICATION FORMED PREPARATION OBTAINED, AND PROCESS FOR PREPARING A COMPOUND, SUITABLE FOR USE IN PREPARED USE.
NL174348B (en) METHOD FOR MANUFACTURING PHARMACEUTICAL PREPARATIONS AND METHOD FOR PREPARING COMPOUNDS SUITABLE FOR USE IN THE FOREGOING METHOD
NL147732B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH ANTI-ALLERGIC ACTION AND THE MEDICINAL PRODUCTS THEREFORE OBTAINED, AS WELL AS A PROCEDURE FOR THE PREPARATION OF MEDICINAL CHROMON DERIVATIVES.
NL163229C (en) METHOD FOR PREPARING A PHOTOPOLYMERISABLE PREPARATION AND ARTICLES MANUFACTURED USING THE PREPARATION SO PREPARED.
NL179203C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH BETA-ADRENERGICLY BLOCKING EFFECT AND METHOD FOR PREPARING AN N-SUBSTITUTED 1-PHENOXY-3-AMINOPROPAN-2-OL SUITABLE FOR APPLICATION
NL163221C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION WITH INFLAMMATIC ACTION, PREPARED THROUGH USE THEREOF, AND PROCESS FOR PREPARING A 21-MERCAPTOSTEROID SUITABLE FOR USE.
NL175410C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH ANTI-HISTAMINIC, SOURCE CHODILATORY AND ANTI-ALLERGIC EFFECT, PRODUCED PHARMACEUTICAL PREPARATIONS OBTAINED THEREFROM, AND METHOD FOR PREPARING FOR A PREPARED PROPERTY.
NL181331C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION, WITH GASTRINE ACTION BASED ON A HEPTAPEPTIDE AND METHOD FOR PREPARING SUCH HEAPAPEPIDE
NL161445C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION; THE PREPARATIONS PREPARED USING THIS METHOD AND METHOD FOR PREPARING A SUBSTITUTED PHENYLGUANIDINE DERIVATIVE.
NL166399C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH ANTI-INFLAMMATORY EFFECT, THE MEDICINAL PRODUCTS OBTAINED THEREOF, AND METHOD FOR PREPARING ANTI-INFLAMMATICALLY ACTIVE.
NL164273C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BASED ON A PROSTAGLANDINE DERIVATIVE, THE PREPARED PHARMACEUTICAL PREPARATION, AND A METHOD FOR PREPARING A PROSTAGLANDINE DERIVATIVE SUITABLE FOR SUCH APPLICATION.
NL173643C (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL176267C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND A CEPHALOSPORIC ACID DERIVATIVE WITH ANTI-BAKERIAL ACTION.
NL178597C (en) METHOD FOR PREPARING A RODENTICIDE PREPARATION AND A MEDICINAL PRODUCT WITH ANTICOAGULATING ACTION, AND METHOD FOR PREPARING SUITABLE CUMARINE DERIVATIVES
NL168517C (en) PROCESS FOR PREPARING A PREPARATION WITH A CYTOTOXIC AND / OR GANGLIOPLEGIC EFFECT, PREPARED FORMED PREPARATIONS USING THIS PROCESS, AND PROCESS FOR THE PREPARATION OF HETEROCYCLIC, PREVIOUSLY PROVEN, HAVING PROPERTY USED.
NL180978B (en) METHOD FOR MANUFACTURING A PHARMACEUTICAL PREPARATION WITH SECRETORIC AND / OR ANTI-COUGHTING ACTION, AND A METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING METHOD
NL178690C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION WITH A CALMING AND ANTI-COMPOSITIVE ACTION, AND A METHOD FOR PREPARING A COMPOUND, SUITABLE FOR USE IN THIS METHOD
NL177918C (en) METHOD FOR PREPARING A MEDICINAL PRODUCT WITH BETA-ADRENERGICLY BLOCKING ACTION USING CARBOSTYRIL DERIVATIVES, AND METHOD FOR PREPARING CARBOSTYRIL DERIVATIVES, SUITABLE FOR SUCH AMOUNT OF THE SAME
NL171707C (en) METHOD FOR PREPARING OR MANUFACTURING A MEDICINAL PRODUCT WITH HYPOGLYCAEMIC ACTION AND METHOD FOR PREPARING A MEDICINAL COMPOUND, SUITABLE FOR USE IN PREVIOUS METHOD
NL161154C (en) METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING A 4-OXAZOLINE-2-ON DERIVATIVE, FORMED PREPARATION AND METHOD FOR PREPARING A COMPOUND SUITABLE FOR USE IN THE FOREGOING PROCESS
NL177750C (en) METHOD FOR PREPARING, RESPECTIVELY MANUFACTURING, A PHARMACEUTICAL PREPARATION WITH A HEART EFFECT AND METHOD FOR PREPARING USE THEREOF NEW ISOCHINOLINE DERIVATIVES
NL166397C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION, BASED ON AN ALFA-CINNAMYLIDEENAMINO-GUANIDINE, THE PREPARED PRODUCT USING THIS PROCESS, AMENDOUS AMINO-PROCIDE AND PROTEIN IN THE SAID METHOD.
NL176746C (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTIHYPERTENSIVE ACTION, AND PRODUCTS OBTAINED BY USE THEREOF
NL174042C (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS BASED ON A 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVAAT, AND METHOD FOR PRODUCING 5-Substituted-5-FENYLALKYLBARBITUURZUURDERIVATEN, SUITABLE FOR USE IN SUCH PREPARATIONS.
NL170956B (en) PROCESS FOR PREPARING PHARMACEUTICAL PREPARATIONS WITH ANTICOVULSIVE ACTION BASED ON S-TRIAZOLOŸ4,3-AŸŸ1,4ŸBENZODIAZEPINE DERIVATIVES, AND PROCESS FOR PREPARING MEDICINAL COMPOUNDS SUITABLE FOR USE IN THESE PROCEDURES.

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: MERRELL DOW PHARMACEUTICALS INC.

V4 Discontinued because of reaching the maximum lifetime of a patent